SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-22-000080
Filing Date
2022-11-16
Accepted
2022-11-16 16:47:47
Documents
15
Period of Report
2022-11-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20221114.htm   iXBRL 8-K 43280
2 EX-3.1 a31.htm EX-3.1 6723
3 EX-3.2 a32.htm EX-3.2 2899
4 EX-99.1 a991.htm EX-99.1 11316
  Complete submission text file 0001005286-22-000080.txt   213427

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20221114.xsd EX-101.SCH 1981
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20221114_lab.xml EX-101.LAB 25138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20221114_pre.xml EX-101.PRE 13124
9 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20221114_htm.xml XML 11549
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 221395781
SIC: 2834 Pharmaceutical Preparations